EP1175504A4 - Dna encoding the human vanilloid receptor vr1 - Google Patents
Dna encoding the human vanilloid receptor vr1Info
- Publication number
- EP1175504A4 EP1175504A4 EP00922143A EP00922143A EP1175504A4 EP 1175504 A4 EP1175504 A4 EP 1175504A4 EP 00922143 A EP00922143 A EP 00922143A EP 00922143 A EP00922143 A EP 00922143A EP 1175504 A4 EP1175504 A4 EP 1175504A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- dna encoding
- vanilloid receptor
- human vanilloid
- human
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29270099A | 1999-04-15 | 1999-04-15 | |
US292700 | 1999-04-15 | ||
PCT/US2000/009897 WO2000063415A1 (en) | 1999-04-15 | 2000-04-13 | Dna encoding the human vanilloid receptor vr1 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1175504A1 EP1175504A1 (en) | 2002-01-30 |
EP1175504A4 true EP1175504A4 (en) | 2002-07-31 |
Family
ID=23125812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00922143A Withdrawn EP1175504A4 (en) | 1999-04-15 | 2000-04-13 | Dna encoding the human vanilloid receptor vr1 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1175504A4 (en) |
JP (1) | JP2003520022A (en) |
AU (1) | AU4237400A (en) |
CA (1) | CA2370570A1 (en) |
WO (1) | WO2000063415A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4444493B2 (en) | 1997-08-20 | 2010-03-31 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Nucleic acid sequences encoding capsaicin receptors and capsaicin receptor related polypeptides and uses thereof |
GB9907097D0 (en) | 1999-03-26 | 1999-05-19 | Novartis Ag | Organic compounds |
US6482611B1 (en) | 1999-09-23 | 2002-11-19 | Neurogen Corporation | Human capsaicin receptor and uses thereof |
EP1170365A1 (en) * | 2000-07-04 | 2002-01-09 | Smithkline Beecham Plc | Member of the ion channel family of polypeptides; vanilrep4 |
EP1313768B1 (en) | 2000-09-02 | 2008-02-06 | Grünenthal GmbH | Antisense oligonucleotides against vr1 |
DE10043674A1 (en) * | 2000-09-02 | 2002-03-21 | Gruenenthal Gmbh | New antisense oligonucleotides and ribozymes, useful for treating e.g. pain and for diagnosis, are directed against mRNA for vanilloid-family receptors |
GB0128161D0 (en) * | 2001-11-23 | 2002-01-16 | Merck Sharp & Dohme | Receptor protein |
CN1984906A (en) | 2004-07-15 | 2007-06-20 | 日本烟草产业株式会社 | Condensed benzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR1) activity |
US7906508B2 (en) | 2005-12-28 | 2011-03-15 | Japan Tobacco Inc. | 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (VRI) activity |
GB201918103D0 (en) * | 2019-12-10 | 2020-01-22 | Oblique Therapeutics Ab | Epitopes and antibodies |
CN111455470A (en) * | 2020-04-09 | 2020-07-28 | 嘉兴菲沙基因信息有限公司 | Small fragment DNA library construction method capable of improving data quality of Hi-C library |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999009140A1 (en) * | 1997-08-20 | 1999-02-25 | The Regents Of The University Of California | Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof |
WO1999037675A1 (en) * | 1998-01-22 | 1999-07-29 | The Regents Of The University Of California | Nucleic acid sequences encoding capsaicin receptors |
EP0943683A1 (en) * | 1998-03-10 | 1999-09-22 | Smithkline Beecham Plc | Human vanilloid receptor homologue Vanilrep1 |
-
2000
- 2000-04-13 WO PCT/US2000/009897 patent/WO2000063415A1/en not_active Application Discontinuation
- 2000-04-13 JP JP2000612492A patent/JP2003520022A/en active Pending
- 2000-04-13 EP EP00922143A patent/EP1175504A4/en not_active Withdrawn
- 2000-04-13 CA CA002370570A patent/CA2370570A1/en not_active Abandoned
- 2000-04-13 AU AU42374/00A patent/AU4237400A/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999009140A1 (en) * | 1997-08-20 | 1999-02-25 | The Regents Of The University Of California | Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof |
WO1999037675A1 (en) * | 1998-01-22 | 1999-07-29 | The Regents Of The University Of California | Nucleic acid sequences encoding capsaicin receptors |
EP0943683A1 (en) * | 1998-03-10 | 1999-09-22 | Smithkline Beecham Plc | Human vanilloid receptor homologue Vanilrep1 |
Non-Patent Citations (1)
Title |
---|
See also references of WO0063415A1 * |
Also Published As
Publication number | Publication date |
---|---|
AU4237400A (en) | 2000-11-02 |
WO2000063415A8 (en) | 2001-01-18 |
JP2003520022A (en) | 2003-07-02 |
CA2370570A1 (en) | 2000-10-26 |
EP1175504A1 (en) | 2002-01-30 |
WO2000063415A1 (en) | 2000-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0201438A3 (en) | Dna vaccine - pcv | |
DE60014382D1 (en) | Joystick | |
GB9913536D0 (en) | Use | |
IL145995A0 (en) | Use | |
GB9907812D0 (en) | Sequencing | |
EP1175504A4 (en) | Dna encoding the human vanilloid receptor vr1 | |
IL146151A0 (en) | Human-g-protein receptor | |
EP1100896A4 (en) | Dna encoding snorf33 receptor | |
EP1144628A3 (en) | Human vanilloid receptor gene | |
HK1028566A1 (en) | Isolated dna encoding human h3histamine receptor | |
EP1242453A4 (en) | Dna encoding snorf62 and snorf72 receptors | |
GB9901622D0 (en) | Construction system | |
GB0018698D0 (en) | Dome construction | |
AU6878200A (en) | Novel receptors and genes encoding the same | |
EP1181316A4 (en) | DNA ENCODING SNORF36a AND SNORF36b RECEPTORS | |
GB9905644D0 (en) | Dna | |
GB9810920D0 (en) | Therapeutic use | |
GB9812662D0 (en) | Therapeutic use | |
GB9816897D0 (en) | Therapeutic use | |
GB9919971D0 (en) | Use | |
GB9911238D0 (en) | Therapeutic use | |
GB9811624D0 (en) | Therapeutic use | |
GB9821179D0 (en) | Therapeutic use | |
EP1225220A4 (en) | Dna encoding endo-beta-galactosidase | |
AU5934800A (en) | Dna encoding orphan snorf40 receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20011107 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: HUVAR, RENE Inventor name: ROGERS, KATHRYN, E. Inventor name: ERLANDER, MARK Inventor name: DUBIN, ADRIENNE Inventor name: HUVAR, ARNE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20020619 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20041013 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20050224 |